MAWBEY GROUP PRACTICE — All Prescriptions & Medications — Page 4
Practice Code: G85130 | LONDON, SW8 2UD
Showing results 151-200 of 509
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Vortioxetine | 134 | 3,206 | £3.0K | +93.1% ▲ |
| Methotrexate | 134 | 4,428 | £1.2K | -58.8% ▼ |
| 134 | 1,655 | £710 | -46.3% ▼ | |
| Fluticasone furoate/vilanterol | 132 | 247 | £6.0K | -14.7% ▼ |
| Other individually formulated bought in preparations | 130 | 1,506 | £145 | +297.9% ▲ |
| Dexamethasone | 129 | 710 | £443 | -25.0% ▼ |
| Zopiclone | 126 | 1,785 | £79 | -77.2% ▼ |
| Methylphenidate hydrochloride | 126 | 6,396 | £4.6K | -51.2% ▼ |
| Dorzolamide and timolol | 121 | 4,790 | £3.5K | -15.5% ▼ |
| Nefopam hydrochloride | 120 | 4,842 | £220 | +6.1% ▲ |
| Felodipine | 119 | 5,144 | £830 | -80.0% ▼ |
| Fluticasone furoate | 118 | 182 | £1.2K | -39.1% ▼ |
| Loratadine | 117 | 4,854 | £120 | -44.0% ▼ |
| Estriol | 116 | 1,489 | £3.3K | -45.5% ▼ |
| Paroxetine hydrochloride | 114 | 4,028 | £416 | -38.9% ▼ |
| Fusidic acid | 114 | 2,040 | £263 | -10.7% ▼ |
| Imipramine hydrochloride | 113 | 840 | £44 | +343.2% ▲ |
| 113 | 127 | £733 | -52.2% ▼ | |
| 113 | 127 | £175 | -48.7% ▼ | |
| Co-amoxiclav (Amoxicillin/clavulanic acid) | 111 | 2,425 | £319 | -27.3% ▼ |
| Vitamins caps | 111 | 1,366 | £34 | +102.0% ▲ |
| Cefalexin | 110 | 2,004 | £168 | -5.4% ▼ |
| Fluticasone/umeclidinium/vilanterol | 109 | 172 | £7.3K | -53.5% ▼ |
| Olopatadine | 109 | 965 | £939 | +148.5% ▲ |
| Tadalafil | 107 | 1,946 | £476 | -37.1% ▼ |
| Pravastatin sodium | 105 | 4,256 | £210 | -67.7% ▼ |
| Diclofenac diethyl | 105 | 14.3K | £786 | -70.4% ▼ |
| Clobetasol propionate | 104 | 6,965 | £651 | -23.8% ▼ |
| Carvedilol | 103 | 3,108 | £128 | -9.2% ▼ |
| 103 | 178 | £7.8K | -66.8% ▼ | |
| Lurasidone | 102 | 714 | £1.9K | +308.8% ▲ |
| Betahistine hydrochloride | 100 | 5,481 | £206 | -58.1% ▼ |
| Tacrolimus | 100 | 3,900 | £3.1K | +85.5% ▲ |
| Lisdexamfetamine dimesylate | 99 | 2,996 | £7.0K | -17.1% ▼ |
| Adrenaline | 98 | 245 | £14.6K | +55.4% ▲ |
| Calcipotriol | 98 | 6,930 | £4.0K | -42.4% ▼ |
| Nortriptyline | 96 | 12.0K | £1.2K | -34.0% ▼ |
| Progesterone | 95 | 8,556 | £1.7K | -77.3% ▼ |
| Ketoconazole | 95 | 12.2K | £2.1K | -3.3% ▼ |
| Lidocaine hydrochloride | 94 | 4,186 | £3.8K | -45.5% ▼ |
| Timolol and bimatoprost | 93 | 2,265 | £3.1K | -38.7% ▼ |
| Co-careldopa (Carbidopa/levodopa) | 92 | 14.0K | £1.2K | -59.3% ▼ |
| Ferrous gluconate | 92 | 3,969 | £116 | +92.4% ▲ |
| Mesalazine (Systemic) | 91 | 17.3K | £9.4K | -62.0% ▼ |
| Clonazepam | 91 | 3,602 | £478 | -41.6% ▼ |
| Aciclovir | 91 | 5,352 | £228 | -38.8% ▼ |
| Isophane insulin | 91 | 710 | £3.1K | -13.8% ▼ |
| Dorzolamide | 91 | 8,385 | £3.3K | +9.5% ▲ |
| Dulaglutide | 90 | 507 | £9.3K | -21.5% ▼ |
| Tranexamic acid | 89 | 5,982 | £388 | +5.0% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.